DrugSupplement
Bentonite clinical trials
- studies test it
- 8
- open now
- 0
- in phase 3
- 3
- first study started
- 2005
How studies write it
Studies that test it under each name
Brand
Other names
Combined with it in one product
Studies by the year they started
8 studies that test it; most in 2006 (2)
| Year | Studies |
|---|---|
| 2005 | 1 |
| 2006 | 2 |
| 2013 | 1 |
| 2014 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2020 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 1
- Phase 2
- 2
- Phase 3
- 3
- Phase 4
- 2
- No phase
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 4 · Other 4
Ipsen (4) · Ain Shams Maternity Hospital (1) · Luca Ronfani (1) · Tianjin Medical University Cancer Institute and Hospital (1) · Centre Francois Baclesse (1)
Often tested with
Tested in the same studies.
Loperamide (2) · Lactobacillus bulgaricus/Bifidobacterium longum/Streptococcus thermophilus-based Probiotic Supplement (1)
Studies
Open first, then newest update. How each study uses Bentonite is read from its arms, and is right about nine times in ten.
Testing it · 8
- Evaluation of Smectite Effect As A Food Thickener On Gastroesophageal Reflux Disease In Neonates Using Combined Esophageal Multichannel Intraluminal ImpedanceCompletedPhase 4Ain Shams Maternity HospitalNCT04788485Written as Diosmectite
- Prevention and Treatment of Pyrrolitinib-associated DiarrheaStatus unknownPhase 2/3Tianjin Medical University Cancer Institute and HospitalNCT04736186Written as Loperamide and montmorillonite powder
- Study to Evaluate Smecta® vs Placebo on the Time to Recovery Following an Acute Diarrhoea Episode in AdultsCompletedPhase 4IpsenNCT00276328Written as Diosmectite (Smecta®)
- Effectiveness of Smecta in Combination With Oral Rehydration in the Treatment of Acute Watery Diarrhoea in Infants and ChildrenCompletedPhase 3IpsenNCT00352989Written as Smecta (Diosmectite), duration of treatment - 7 days
- Effectiveness of Smecta in the Treatment of Acute Diarrhoea in ChildrenCompletedPhase 3IpsenNCT00352716Written as Smecta (Diosmectite), duration of treatment - 7 days
- Chronic Administration of Diosmectite (SMECTA®) in Subjects With Chronic DiarrhoeaCompletedPhase 1IpsenNCT03045926Written as Diosmectite (Smecta®)
- Protein Sorbent Properties of Montmorillonite in Vitro and in Vivo ModelsCompletedNot applicableLuca RonfaniNCT02124330Written as montmorillonite 5 g
- Evaluation of the Efficacy of Low-dose Acetylsalicylic Acid on Diarrhea Induced by Anti-cancer Targeted Therapies.WithdrawnPhase 2Centre Francois BaclesseNCT02323516Written as diosmectite + loperamide
Codes
What other systems call Bentonite · ClinicalTrials.gg INT007053
- MeSH (NLM) D001546BentoniteConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) A585MN1H2LMONTMORILLONITEConfirmed FDA, NLM
- RxNorm 1425919One source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D001546 | Bentonite | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | A585MN1H2L | MONTMORILLONITE | Confirmed FDA, NLM |
| RxNorm | 1425919 | — | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.